Skip to content
Trial Eligibility
Menu

Time Restricted Eating (TRE) in Bipolar Disorder

NCT07211217

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is a randomized controlled trial investigating the effects of an 8-TRE intervention compared to a wait list (control) on metabolic health and body composition in people diagnosed with BD and who are currently obese and at least mildly depressed. Following a 1-week baseline assessment, participants will be randomized to either a TRE or the wait list (1-to-1 ratio) for 8 weeks. At baseline, Week 8 (post treatment), and Week 20 (follow-up), investigators will assess daily eating patterns for one week, followed by collection of fasting lipids, body weight and vital signs.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Bipolar Disorder (BD)
  • Bipolar Disorder Depression
  • Overweight (BMI > 30)

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Massachusetts General Hospital
Last updated on ClinicalTrials.gov
October 7, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Massachusetts General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.